Accessibility Menu
 
Amgen logo

Amgen

(ETR) AMG

Current Price$305.05
Market Cap$164.63B
Since IPO (1999)+676%
5 Year+45%
1 Year+7%
1 Month-6%

Amgen Financials at a Glance

Market Cap

$164.63B

Revenue (TTM)

$36.75B

Net Income (TTM)

$7.71B

EPS (TTM)

$12.56

P/E Ratio

24.31

Dividend

$8.36

Beta (Volatility)

0.02 (Low)

Price

$305.05

Volume

464

Open

$306.40

Previous Close

$305.05

Daily Range

$304.20 - $308.65

52-Week Range

$230.00 - $333.00

AMG News

No articles available.

AMG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amgen

Industry

Biotechnology

Employees

31,500

CEO

Robert A. Bradway, MBA

Headquarters

Thousand Oaks, CA 91320-1799, US

AMG Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

28%

Net Income Margin

21%

Return on Equity

104%

Return on Capital

16%

Return on Assets

9%

Earnings Yield

4.11%

Dividend Yield

0.03%

Payout Ratio

66.45%

Stock Overview

Market Cap

$164.63B

Shares Outstanding

539.07M

Volume

464

Short Interest

0.00%

Avg. Volume

811

Financials (TTM)

Gross Profit

$30.33B

Operating Income

$14.89B

EBITDA

$16.90B

Operating Cash Flow

$9.96B

Capital Expenditure

$1.86B

Free Cash Flow

$8.10B

Cash & ST Invst.

$9.13B

Total Debt

$54.61B

Amgen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$9.87B

+8.6%

Gross Profit

$6.89B

+15.3%

Gross Margin

69.83%

N/A

Market Cap

$164.63B

N/A

Market Cap/Employee

$5.88M

N/A

Employees

28,000

N/A

Net Income

$1.33B

+112.6%

EBITDA

$3.30B

+12.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$45.48B

+5.5%

Accounts Receivable

$9.57B

+27.6%

Inventory

$6.23B

-11.0%

Long Term Debt

$50.01B

-11.6%

Short Term Debt

$4.60B

+29.6%

Return on Assets

8.51%

N/A

Return on Invested Capital

15.81%

N/A

Free Cash Flow

$961.00M

-78.2%

Operating Cash Flow

$1.60B

-66.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GIS.DEGilead Sciences, Inc.
$118.30-0.87%
PFE.DEPfizer Inc.
$23.71-1.19%
PFE.FPfizer Inc.
$23.64-1.50%
DAP.DEDanaher Corporation
$159.30-2.31%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About AMG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.